At-Home Cancer Testing Kits Market Size (2024 – 2030)

The Global At-Home Cancer Testing Kits Market was valued at $6.52 billion in 2023 and is projected to reach a market size of $9.24 billion by 2030. Over the forecast period of 2024-2030, market is projected to grow at a CAGR of 5.1%.

People can use at-home cancer testing kits as diagnostic tools in their homes to do fast tests and get findings right away. They help discover and screen for cancer at an earlier, more treatable stage sometimes even before symptoms appear. Depending on the type of test, a sample of blood, urine, faeces, saliva, or a vaginal swab may need to be collected. Certain tests require the samples to be submitted to a lab for analysis, but others may be finished entirely at home. The most frequent kinds of cancer are lung, colorectal, and liver cancers. According to data from the World Health Organisation (WHO), cancer is the leading cause of death and led to nearly 10 million deaths in 2020. Fast cancer identification made possible by cancer test kits allows people to start treatment early and ward off the disease. The kits detect tumour cells and tumour markers in blood by using a variety of immunoassays and biochemical assay-based techniques. Recently, there has been a surge in the popularity of home test kits because of patients' rising preference to self-diagnose in the convenience of their own homes. Biological samples like blood and faeces, together with the presence of certain viruses like the Human Papillomavirus (HPV), are used as indicators to identify cancer early on. Prominent companies are expected to initiate a growing number of R&D initiatives to expedite detection and incorporate software into cancer test kits throughout the projected period.

Key Market Insights:

In 2023, the global market for self-testing, which includes cancer testing kits, was estimated to be worth USD 15 billion. This noteworthy statistic emphasises how self-testing for a variety of illnesses, including cancer, is becoming more and more popular. The development of technology is essential for market expansion. By 2031, the market for at-home testing kits is projected to grow to a value of around USD 25 billion. This estimated rise shows how technology advancements are expected to affect the variety of malignancies diagnostic kits can detect, their accuracy, and their simplicity of use.
Global At-Home Cancer Testing Kits Market Drivers:

Some market variables for at-home cancer test kits are the following: cost, timeliness, and convenience of these products:
At-home cancer testing kits provide convenience and accessibility for those who do not have easy access to medical facilities or who would rather test in private at home. These kits allow consumers to gather samples and perform testing in the comfort of their own homes. This can be especially beneficial for those who live in remote areas, have limited mobility, or have busy lives that make it difficult to go to a medical facility for testing. By allowing the user to test at home, these kits reduce the need for travel and the waiting times associated with clinic appointments. They also allow consumers to choose and maintain the privacy of their medical records by offering discretion and privacy. Furthermore, at-home cancer testing kits usually come with easy-to-use materials and instructions, which make it easier for users to gather samples and accurately complete the tests. Many kits additionally include online or phone support for any questions or concerns that customers may have during the testing process.

Early detection of cancer with at-home cancer testing kits is crucial for effective treatment and improved patient outcomes:
With the use of these kits, individuals may collect samples—like blood, urine, or stool—in the convenience of their own homes and send them to a lab for analysis. After that, the samples are analysed to look for specific biomarkers or genetic changes connected to different kinds of cancer. If any abnormalities are discovered, people are advised to follow up with their medical providers for additional evaluation and treatment. At-home cancer testing kits can help in the early detection of cancer by providing patients with affordable and easily available means to assess their risk of developing a particular kind of cancer or to track their present status. These kits can also help those who might not have access to regular medical care or who might face barriers like misinformation, fear, or stigma. Certain tests can detect substances released by cancer cells prior to the onset of symptoms, such as blood in the stool or changes in DNA in saliva. For additional testing, several of these kits can also provide you access to a licenced laboratory or a doctor's visit.

Global At-Home Cancer Testing Kits Market Restraints and Challenges:

The cost of diagnostic kits is one of the primary obstacles preventing the market from earning more money. Patients may be discouraged from adopting cancer screening kits because of the high initial cost of the kits, which they may use comfortably in their own homes. Cancer Screening Test kits can cost anywhere from $30 to $90, with subscription discounts. This puts a heavy financial burden on the healthcare system. Medical expenses have skyrocketed during the last ten years, rising by a staggering 27% in 2020. The National Cancer Institute estimates that the cost of cancer-related medical bills had a 150-billion-dollar national economic effect. Technology issues with sample collection and storage as well as possible false positive results from cancer test kits are other factors that are expected to limit market revenue growth during the forecast timeframe.

Global At-Home Cancer Testing Kits Market Opportunities:

There is a tonne of intriguing potential in the worldwide market for at-home cancer diagnostic kits. The need for these practical and easily available testing alternatives is being driven by an increasing recognition of the significance of early diagnosis, which is essential for effective cancer therapy. Technological developments are enabling these kits to screen for a greater variety of malignancies and to be more precise and easier to use. In addition, the growth of telemedicine removes geographical restrictions and guarantees prompt access to advice by enabling virtual discussions with medical specialists after a test. People are using at-home testing kits more often to proactively check their health as the emphasis on preventive healthcare grows, which is driving this market's rapid expansion.

AT-HOME CANCER TESTING KITS MARKET REPORT COVERAGE:

Global At-Home Cancer Testing Kits Market Segmentation: By Sample Type

• Blood

• Urine

• Saliva

The at-home cancer test kit market segment with the fastest pace of expansion is blood-based testing kits. One diagnostic method that regularly involves blood samples is cancer screening. The advantage of blood-based testing kits is their capacity to detect specific genetic abnormalities or biomarkers associated with cancer. These kits sometimes use state-of-the-art techniques to identify blood-based cancer markers, such as DNA sequencing or immunoassays. Blood-based testing kits are becoming more and more common because of their accuracy, usefulness, and ability to detect a range of malignancies. Many at-home cancer screening kits on the market are urine-based testing kits. Urine samples can be used to identify specific cancer biomarkers or metabolites. Urine-based test kits are easy to use, non-invasive, and may be performed at home without the need for specialised equipment. These kits are particularly useful for the early diagnosis of bladder cancer and some types of kidney cancer. The urine-based testing kits' dominance can be attributed to their simplicity of use, affordability, and widespread availability.

Global At-Home Cancer Testing Kits Market Segmentation: By Distribution Channel

• Retail pharmacies

• Online pharmacies

• Direct-to-consumer Platforms

Out of all the categories, the retail pharmacy segment now controls the largest portion of the market. This is primarily due to the widespread presence of retail pharmacies, which facilitate easy access to cancer diagnostic kits for consumers at home. Retail pharmacies offer a dependable and easy way to purchase medical goods, including cancer diagnostic kits. Retail pharmacies often have licenced chemists on staff who can provide clients with advice on how to correctly use these testing kits. Still, it is expected that the online pharmacy sector would grow at the fastest rate in the future years. Because internet shopping is so convenient and e-commerce is becoming more and more popular, there are more and more online pharmacies. Online pharmacies provide a range of medical goods, including at-home cancer testing kits, along with the ease of doorstep delivery. Because of the COVID-19 pandemic, individuals are preferring to avoid traditional pharmacies and isolate themselves online, which has increased the popularity of online pharmacies.

Global At-Home Cancer Testing Kits Market Segmentation: By Region

• North America 

• Asia-Pacific 

• Europe 

• South America 

• Middle East and Africa

It is anticipated that North America will lead the global market for at-home cancer testing kits due to the high incidence of cancer in this region and the extensive usage of state-of-the-art goods and technologies for cancer detection and management. Europe is expected to lag North America in terms of market share because of the region's significant players and manufacturers, as well as the rising demand and awareness for at-home cancer testing kits. The at-home cancer testing kits market is expected to develop at the quickest rate in the globe in Asia-Pacific due to the region's growing rates of cancer incidence, rising disposable income, and rising healthcare expenses.

COVID-19 Impact Analysis on the Global At-Home Cancer Testing Kits Market:

The at-home cancer testing business has been significantly impacted by the COVID-19 pandemic. Lockdown procedures intended to stem the virus's spread have caused several operations related to production, processing, supply, distribution, import, export, and other aspects of the at-home cancer testing sector to be suspended. There are still opportunities in the market for at-home cancer diagnostics, despite these barriers. These prospects include declining prices, interruptions to import and export, fewer manufacturing and processing jobs, fewer supply and distribution lines, and an uncertain future. Social isolation is the primary factor reducing COVID-19 cases and halting the virus's spread. After the COVID-19 pandemic, hospitals stopped and subsequently reduced non-emergency operations to save money and stop the spread of new coronaviruses. As a result, stool-based screening tests that patients perform at home—long overshadowed by colonoscopy—are becoming more and more popular. Home kits for testing for colon cancer have been released by a limited number of firms. Patient visits to physicians decreased because of the need that the test be completed at home. Patients are not obliged to visit a hospital, diagnostic centre, or clinic to get cancer testing.

Recent Trends and Developments in the Global At-Home Cancer Testing Kits Market:

Worldwide At-Home Kits for Cancer Testing Market dynamics are dynamically changing. The industry is seeing an increase of cancer-specific kits, such as HPV tests for cervical cancer, which enable people to focus their health monitoring, driven by the public's rising emphasis on early diagnosis. Biosensor technology and better algorithms are two examples of how technological developments are improving test accuracy and user confidence. Users may easily track and manage their outcomes thanks to process optimisation brought about by integration with digital health platforms and mobile apps. As a result of regulatory agencies seeing this potential, more and better kits are being approved, expanding the alternatives available to consumers. In the future, research on non-invasive, alternative sample collection techniques like faeces or saliva tests promises to push the boundaries of this quickly changing market by making testing even more comfortable.

Key Players:

1. Abingdon Health Quidel Corporation

2. ELITech Group SAS

3.  Everlywell, Inc.

4. Exact Sciences Corp.

5. GY Highland Biotech LLC

6. iDNA

7. Laboratory Corporation of America Holdings

8. Lepu Medical Technology Co., Ltd.

9.  Pinnacle Biolabs

10. ulti med Products GmbH